No relationship between the ins del polymorphism of the serotonin transporter promoter and pain perception in fibromyalgia patients and healthy controls
Authors:
- Annie LaroucheALAnnie Larouche
- Edith NormandENEdith Normand
- Juliana Barcellos de SouzaJSJuliana Barcellos de Souza
- Isabelle GaumondIGIsabelle Gaumond
- Serge MarchandSMSerge Marchand
- Sylvain GrignonSGSylvain Grignon
- 1 August 2010
- journal article
- Published by Wiley in European journal of pain
- Vol. 14 (7) , 742-746
Abstract
Background:In animals, decades of research have shown that serotonin (5‐HT) is involved in endogenous pain inhibition systems, which are deficient in chronic pain disorders such as fibromyalgia (FM). In humans, there is preliminary evidence showing that 5‐HT is involved in the FM pathophysiology. In the current endophenotyping study, we sought to investigate, for the first time in humans, the relationships between the serotonin transporter promoter region (5‐HTTLPR) polymorphism and experimentally‐induced pain perception/inhibition in healthy controls (HC) and FM patients.Methods:Participants were 58 FM patients and 60 HC, who did not differ in age, sex or menstrual cycle. Thermal stimuli were used to measure pain thresholds. Pain inhibition was elicited using a tonic thermal test (Peltier thermode) administered before and after activation of the diffuse noxious inhibitory controls (DNIC) by means of a cold‐pressor test (CPT).Results:Thermal pain thresholds were higher in HC compared to FM patients. Pain ratings during the CPT were lower in HC, relative to FM patients. Also, DNIC efficacy was stronger in HC compared to FM patients. However, there was no relationship between 5‐HTTLPR and experimentally‐induced pain perception/inhibition.Discussion:Our results further confirm that FM is associated with thermal hyperalgesia and deficient DNIC. However, we found no evidence showing that the 5‐HTTLPR polymorphism influences pain perception and DNIC. Potential reasons for this negative result will be discussed. Further endophenotyping studies of 5‐HT‐related gene polymorphisms are required to ascertain the potential relationships between 5‐HT and human pain perception/inhibition.Keywords
This publication has 38 references indexed in Scilit:
- Alteration of serotonin transporter density and activity in fibromyalgiaArthritis Research & Therapy, 2006
- Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndromeArthritis Research & Therapy, 2006
- L'Échelle de dramatisation face à la douleur PCS-CF: Adaptation canadienne en langue française de l'échelle «Pain Catastrophizing Scale».Canadian Journal of Behavioural Science / Revue canadienne des sciences du comportement, 2005
- Medically Unexplained Physical Symptoms, Anxiety, and DepressionPsychosomatic Medicine, 2003
- Association Between a Functional Catechol O-Methyltransferase Gene Polymorphism and Schizophrenia: Meta-Analysis of Case-Control and Family-Based StudiesAmerican Journal of Psychiatry, 2003
- Association of T102C polymorphism of the 5-HT2A receptor gene with pyschiatric status in fibromyalgia syndromeRheumatology International, 2001
- Citalopram in patients with fibromyalgia— a randomized, double‐blind, placebo‐controlled studyEuropean journal of pain, 2000
- The T102C Polymorphism of the 5-HT2A-Receptor Gene in FibromyalgiaNeurobiology of Disease, 1999
- Diffuse noxious inhibitory controls (DNIC) in the rat with or without pCPA pretreatmentBrain Research, 1981
- Endogenous pain control mechanisms: Review and hypothesisAnnals of Neurology, 1978